Key result
Percutaneous mitral valve interventions offer viable options for mitral regurgitation in prohibitive-risk surgical patients.
Why the study?
A significant proportion of elderly patients with moderate or severe mitral valve regurgitation are not eligible for surgical repair or replacement due to prohibitive surgical risk, necessitating development of percutaneous treatment options.
Population
More than 3 million patients in the US with moderate or severe mitral valve regurgitation
Comparison
Percutaneous mitral valve repair/replacement techniques including MitraClip and other catheter-based devices
Design
Review of current and emerging percutaneous mitral valve treatments
Authors
Loading...
May support MitraClip consideration in prohibitive-risk mitral regurgitation; leaves open need for randomized confirmation.
This review highlights the current state and future potential of percutaneous mitral valve interventions, particularly for patients at prohibitive surgical risk.
Athappan et al. (2017) conducted a review in Mitral valve regurgitation. Percutaneous mitral valve repair/replacement techniques was evaluated. Percutaneous mitral valve repair and replacement techniques, notably the MitraClip system, offer promising alternatives for patients with mitral regurgitation who are at prohibitive surgical risk.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: